ST3GAL4 Antikörper (AA 39-184) (HRP)
Kurzübersicht für ST3GAL4 Antikörper (AA 39-184) (HRP) (ABIN7147963)
Target
Alle ST3GAL4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 39-184
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 protein (39-184AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ST3GAL4 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 4 (ST3GAL4))
-
Andere Bezeichnung
- ST3GAL4
-
Hintergrund
-
Background: It may catalyze the formation of the NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc- or NeuAc-alpha-2,3-Gal-beta-1,3-GlcNAc-sequences found in terminal carbohydrate groups of glycoproteins and glycolipids. It may be involved in the biosynthesis of the sialyl Lewis X determinant. Also acts on the corresponding 1,3-galactosyl derivative.
Aliases: ST3GAL4 antibody, CGS23 antibody, NANTA3 antibody, SIAT4C antibody, STZ antibody, CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 antibody, Alpha 2,3-ST 4 antibody, Beta-galactoside alpha-2,3-sialyltransferase 4 antibody, EC 2.4.99.2 antibody, EC 2.4.99.4 antibody, Alpha 2,3-sialyltransferase IV antibody, Gal-NAc6S antibody, Gal-beta-1,4-GalNAc-alpha-2,3-sialyltransferase antibody, SAT-3 antibody, ST-4 antibody, ST3Gal IV antibody, ST3GalIV antibody, ST3GalA.2 antibody, STZ antibody, Sialyltransferase 4C antibody, SIAT4-C antibody
-
UniProt
- Q11206
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-